04/06/2015 - 16:41
CHICAGO – Dr. William J. Gradishar says bevacizumab may not be dead, T-DM1 is definitely not dead, and the jury is still out on bisphosphonates preventing recurrence, based on presentations at the...
Field of Interest: Oncology
Categories:
News Feed: Internal Medicine News - Oncology